Bisphosphonates are currently the medication of choice for both prevention and treatment of glucocorticoid-induced osteoporosis. Teriparatide has been shown to be better than alendronate and might ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

No matter which osteoporosis drug your doctor chooses for you, it's helpful to know as much as possible about how the disease has affected you. One way to tell is to ask about your "markers." ...

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Another drug listed on the rebate list is Evenity, a drug intended to treat osteoporosis in postmenopausal women. Per Eventiy's website, Evenity can cost up to $2,503.74 per month. However ...

Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...